Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer [Phase 2]
Phase 2 trial of MK-0646 (dalotuzumab), an IGF-1 receptor antibody, in stage IIIb/IV metastatic non-squamous non-small cell lung cancer has …
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation [Phase 4]
A Phase 4 clinical trial evaluating icotinib as adjuvant therapy after surgery for EGFR-mutant stage I-IIIB non-small cell lung cancer (lung…
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: EGF Ointment for Erlotinib Skin Lesion [Phase 2]
Phase 2 study updates the use of epidermal growth factor ointment to manage erlotinib-induced skin lesions in patients with non-small cell l…
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update on radiation therapy for patients with stage I non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2014-10-30Clinical Trial Update: Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating vorinostat with carboplatin and paclitaxel for advanced or metastatic non-small cell lung cancer ha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With Erlotinib in KRAS Wild Type Advanced Non-Small Cell Lung Cancer (NSCLC) and a Randomized Phase II Study of AZD6244 With Erlotinib in Mutant KRAS Adva... [Phase 2]
Two randomized Phase II studies evaluated AZD6244 with erlotinib versus erlotinib alone in KRAS wild-type and KRAS-mutant advanced non-small…
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer [Phase 3]
Phase 3 trial update for PF-00299804 in stage IIIB/IV non-small cell lung cancer previously treated, with results posted.
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line Treatment
This clinical trial update reports on a completed study of Bevacizumab plus chemotherapy as first-line treatment for advanced non-small cell…
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers [NA]
This clinical trial update evaluates the use of 4D 18F-FDG PET-CT imaging in radiotherapy planning for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients [Phase 2]
Phase 2 exploratory study evaluating OCZ103-OS in combination with standard of care in Stage IV non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating non-cytotoxic suramin as a chemosensitizer for non-small cell lung cancer was terminated, and results were posted…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: Single Scope Staging of Lung Cancer With Endosonography
This clinical trial update reports the completion of a study evaluating single-scope endosonography for mediastinal staging in non-small cel…
-
CLINICAL_TRIALS trial_result · 2014-10-10Clinical Trial Update: Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating the combination of celecoxib and erlotinib in former smokers with stage IIIB or stage IV non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Evaluation of a Pneumotachograph (SPI) for the Production of PET and CT Acquisitions Synchronized With Breath for the Assessment of Extension of Lung Cancer [NA]
A clinical trial evaluating a Pneumotachograph (SPI) to synchronize PET/CT imaging with breath-hold for assessing extension of non-small cel…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating celecoxib with docetaxel or pemetrexed in advanced recurrent non-small cell lung cancer was terminated, with result…
-
CLINICAL_TRIALS trial_result · 2014-10-07Clinical Trial Update: Role of Rapid On-site Evaluation for Mutational Analysis of EBUS-TBNA Specimens [NA]
This clinical trial update describes the role of rapid on-site evaluation for mutational analysis of EBUS-TBNA specimens in non-small cell l…
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients [Phase 2]
Phase II trial evaluating the combination of capecitabine and docetaxel in patients with previously untreated advanced non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 clinical trial evaluated home-administered pemetrexed as maintenance therapy for advanced nonsquamous non-small cell lung cancer, …
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating whether radiation therapy can prevent central nervous system metastases in patients with non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib [Phase 3]
Phase 3 trial results for LUX-Lung 5 evaluating afatinib plus weekly paclitaxel versus investigator's choice chemotherapy after afatinib in …
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer [Phase 2]
Phase 2 trial of AZD2171 (cediranib) in patients with recurrent non-small cell lung cancer has completed, with results posted in October 201…
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 3]
This Phase 3 trial compared pemetrexed disodium with erlotinib hydrochloride as second-line therapy for advanced non-small cell lung cancer.…
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating docetaxel plus bortezomib in patients with progressive or recurrent non-small cell lung cancer has completed and re…
-
CLINICAL_TRIALS trial_result · 2014-09-30Clinical Trial Update: Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial evaluating cilengitide and cetuximab with platinum-based chemotherapy as first-line treatment for advanced non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Pre-Operative Assessment of Chest Wall Invasion in NSCLC Using Pre-Operative, Surgeon Performed Ultrasound [NA]
A completed clinical trial from CHUM evaluated pre-operative, surgeon-performed ultrasound to assess chest wall invasion in non-small cell l…